As the reviewed literature reports, the prognostic utility of aneuploidy testing and of some immunocytochemical markers of cellular proliferation in CRC (TS, cyclin B1 and D1, PCNA, and Ki-67) needs to be supplemented by modern molecular biology techniques. This evidence concerns the gene PCNA and colorectal carcinoma.